MARKET

AZR

AZR

Azora Therapeutics Inc
NASDAQ
4.880
-0.170
-3.37%
After Hours: 4.480 -0.4 -8.20% 19:52 10/29 EDT
OPEN
4.500
PREV CLOSE
5.05
HIGH
4.970
LOW
3.670
VOLUME
146.92K
TURNOVER
--
52 WEEK HIGH
9.53
52 WEEK LOW
1.310
MARKET CAP
12.81M
P/E (TTM)
-0.2945
1D
5D
1M
3M
1Y
5Y
1D
*News On Adial Pharmaceuticals Inc. (ADIL) Now Under AZR
Dow Jones · 13h ago
Adial Rebrands as Azora Therapeutics, Changes Leadership After Acquisition
Dow Jones · 1d ago
Azora Therapeutics Rebrands and Installs New Leadership Team
TipRanks · 1d ago
Adial Pharmaceuticals changes name to Azora Therapeutics, names new CEO
TipRanks · 1d ago
Adial Pharmaceuticals Says Stockholders Approve Conversion Of Series A Preferred Into 12,930,601 Shares, Raise Authorized Shares To 500,000,000 From 100,000,000
Benzinga · 1d ago
*Azora Therapeutics Names Matt Davidson, Ph.D., Pres and CEO
Dow Jones · 1d ago
*Azora Therapeutics Names Celia Economides, Chief Fincl Officer
Dow Jones · 1d ago
*Azora Therapeutics Common Stk Expected to Begin Trading on Nasdaq Cap Market Under Ticker AZR on Oct 29
Dow Jones · 1d ago
More
About AZR
Adial Pharmaceuticals, Inc. is a biopharmaceutical company. Its lead program is AT177, a proprietary colon‑targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure in development for ulcerative colitis. AT177 is a fully synthetic, patented, oral AhR agonist designed to restore mucosal immune homeostasis at the site of disease with minimal systemic exposure. AT177's active ingredient is a prodrug of indirubin, a potent AhR agonist within indigo naturalis, a botanical extract with clinical efficacy in ulcerative colitis. AT177's colon-targeted formulation delivers therapeutic AhR engagement directly to the colonic mucosa with exquisite gut restriction, minimizing the systemic AhR exposure associated with adverse effects. Its historical investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder in heavy drinking patients.

Webull offers Adial Pharmaceuticals Inc stock information, including NASDAQ: AZR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZR stock methods without spending real money on the virtual paper trading platform.